Investment Reports

Get to know the rationale behind great ideas for you to make sound long term investment decisions.

Refine Search


Date

217/217 Reports

  • Result Update:ACC
    Result Update:ACC

    26 Apr 2024

    Stocks covered (1)

    ACC
    ACC
    We roll over our estimate to FY26 and maintain our BUY recommendation on the stock.
  • Result Update:Bajaj Finance
    Result Update:Bajaj Finance

    26 Apr 2024

    Stocks covered (1)

    We maintain our BUY recommendation on the stock.
  • Result Update:MAS FINANC SER
    Result Update:MAS FINANC SER

    26 Apr 2024

    Stocks covered (1)

    We maintain our BUY recommendation on the stock.
  • Result Update:Tech Mahindra
    Result Update:Tech Mahindra

    26 Apr 2024

    Stocks covered (1)

    Given the uncertainty from the world’s largest economies, we expect delays in decision-making on IT budgets. Keeping this in view, we recommend a SELL on the stocks.
  • Result Update:Dalmia Bharat
    Result Update:Dalmia Bharat

    26 Apr 2024

    Stocks covered (1)

    Recommendation: We maintain our BUY recommendation on the stock.
  • Result Update:Nestle India
    Result Update:Nestle India

    26 Apr 2024

    Stocks covered (1)

    With a 12% upside potential from the CMP, we maintain our BUY rating on the stock.
  • Result Update:Welspun Living
    Result Update:Welspun Living

    26 Apr 2024

    Stocks covered (1)

    We maintain our BUY rating on the stock and value the company at 15 times FY26E. Our TP remains unchanged at Rs 210/share, implying an upside of 35% from the CMP.
  • Result Update:Cyient
    Result Update:Cyient

    26 Apr 2024

    Stocks covered (1)

    With strong growth potential backed by robust deal wins and superior execution capabilities, we maintain our BUY recommendation on the stock.
  • Result Update:Zensar Tech.
    Result Update:Zensar Tech.

    26 Apr 2024

    Stocks covered (1)

    The company's promising recovery prospects bolstered by favourable business deals and enhanced customer retention, we maintain our recommendation to HOLD the stock.